Q Manach1, M Bouquot2, M Rouprêt3, V Ambrogi4, F Richard5, M O Bitker6, E Chartier-Kastler7, V Phé8. 1. Service d'urologie, hôpital universitaire Pitié-Salpêtrière, faculté de médecine Pierre-et-Marie-Curie, Sorbonne universités, université Paris 6, Assistance publique-Hôpitaux de Paris, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. Electronic address: quentinmanach@hotmail.fr. 2. Service d'urologie, hôpital universitaire Pitié-Salpêtrière, faculté de médecine Pierre-et-Marie-Curie, Sorbonne universités, université Paris 6, Assistance publique-Hôpitaux de Paris, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. Electronic address: morganebouquot@hotmail.com. 3. Service d'urologie, hôpital universitaire Pitié-Salpêtrière, faculté de médecine Pierre-et-Marie-Curie, Sorbonne universités, université Paris 6, Assistance publique-Hôpitaux de Paris, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. Electronic address: mroupret@gmail.com. 4. Service de santé publique, informatique médicale et biostatistique, hôpital universitaire Pitié-Salpêtrière, faculté de médecine Pierre-et-Marie-Curie, Sorbonne universités, université Paris 6, Assistance publique-Hôpitaux de Paris, 47-83, boulevard de l'hôpital, 75651 Paris cedex 13, France. Electronic address: amva@hotmail.fr. 5. Service d'urologie, hôpital universitaire Pitié-Salpêtrière, faculté de médecine Pierre-et-Marie-Curie, Sorbonne universités, université Paris 6, Assistance publique-Hôpitaux de Paris, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. Electronic address: francois.richard@aphp.fr. 6. Service d'urologie, hôpital universitaire Pitié-Salpêtrière, faculté de médecine Pierre-et-Marie-Curie, Sorbonne universités, université Paris 6, Assistance publique-Hôpitaux de Paris, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. Electronic address: mo.bitker@aphp.fr. 7. Service d'urologie, hôpital universitaire Pitié-Salpêtrière, faculté de médecine Pierre-et-Marie-Curie, Sorbonne universités, université Paris 6, Assistance publique-Hôpitaux de Paris, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. Electronic address: emmanuel.chartier-kastler@aphp.fr. 8. Service d'urologie, hôpital universitaire Pitié-Salpêtrière, faculté de médecine Pierre-et-Marie-Curie, Sorbonne universités, université Paris 6, Assistance publique-Hôpitaux de Paris, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. Electronic address: veronique.phe@aphp.fr.
Abstract
PURPOSE: To evaluate the long-term functional outcomes after retropubic tension-free vaginal tape (TVT) placement to treat female stress urinary incontinence (SUI). METHODS: From September 1998 to September 2000, we prospectively enrolled all consecutive women in our center suffering SUI caused by urethral hypermobility. All women had a retropubic TVT inserted by the same surgeon. Patients were evaluated at 1, 3, 6 and 12 months postoperatively, and annually thereafter. Postoperative assessment included a measurement of post-voiding residual volume, urinalysis, a 1-hour pad test, a urinary symptom questionnaire, and an assessment of quality-of-life. Objective continence (defined as no urine leakage at clinical examination) and subjective continence (defined as no urine leakage, whatever the mechanism, reported by the patient) were reported. RESULTS: Overall, 58 consecutive women (median age 59; IQR 49-67; min 21-max 78) were evaluated. Median follow-up was 10.2years (IQR 1.4-16.0; min 1-max 13.2). At the last follow-up, objective and subjective continence rates were 93% and 78%, respectively and remained stable in the long run. Pad tests, urinary symptom questionnaire scores and quality-of-life were significantly improved. Self-intermittent catheterisation was required by three women. A section of one TVT and removal of another tape was undertaken in two women with chronic pelvic pain. One patient had a chronic urinary infection. Rate of de novo urgency was 10%. CONCLUSIONS: TVT implantation offered good and stable functional long-term outcomes. This procedure enhanced quality-of-life and had low morbidity. LEVEL OF EVIDENCE: 3.
PURPOSE: To evaluate the long-term functional outcomes after retropubic tension-free vaginal tape (TVT) placement to treat female stress urinary incontinence (SUI). METHODS: From September 1998 to September 2000, we prospectively enrolled all consecutive women in our center suffering SUI caused by urethral hypermobility. All women had a retropubic TVT inserted by the same surgeon. Patients were evaluated at 1, 3, 6 and 12 months postoperatively, and annually thereafter. Postoperative assessment included a measurement of post-voiding residual volume, urinalysis, a 1-hour pad test, a urinary symptom questionnaire, and an assessment of quality-of-life. Objective continence (defined as no urine leakage at clinical examination) and subjective continence (defined as no urine leakage, whatever the mechanism, reported by the patient) were reported. RESULTS: Overall, 58 consecutive women (median age 59; IQR 49-67; min 21-max 78) were evaluated. Median follow-up was 10.2years (IQR 1.4-16.0; min 1-max 13.2). At the last follow-up, objective and subjective continence rates were 93% and 78%, respectively and remained stable in the long run. Pad tests, urinary symptom questionnaire scores and quality-of-life were significantly improved. Self-intermittent catheterisation was required by three women. A section of one TVT and removal of another tape was undertaken in two women with chronic pelvic pain. One patient had a chronic urinary infection. Rate of de novo urgency was 10%. CONCLUSIONS: TVT implantation offered good and stable functional long-term outcomes. This procedure enhanced quality-of-life and had low morbidity. LEVEL OF EVIDENCE: 3.